drugset / Trial / NCT07106372
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, single-arm, open-label phase 3 study to evaluate the safety, efficacy, Pharmacokinetics(PK) and immunogenicity of Stapokibatrt in children with Atopic Dermatitis.
Timeline
- Start
- 2025-09
- Primary completion
- 2027-02
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stapokibatrt | Unknown | — | Subcutaneous |